Works in Prostate Cancer & Prostatic Diseases, 2009, Vol 12, Issue 1

Results: 19

Prostate cancer chemotherapy in the era of targeted therapy.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 13, doi. 10.1038/pcan.2008.32

By:

Michael, A.;
Syrigos, K.;
Pandha, H.

Publication type:

Article

Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA era.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 57, doi. 10.1038/pcan.2008.14

By:

Jones, J. S.;
Follis, H. W.;
Johnson, J. R.

Publication type:

Article

Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 34, doi. 10.1038/pcan.2008.27

By:

Nakano, Y.;
Bilim, V.;
Yuuki, K.;
Muto, A.;
Kato, T.;
Nagaoka, A.;
Tomita, Y.

Publication type:

Article

Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 100, doi. 10.1038/pcan.2008.15

By:

Spitz, I. M.;
Chertin, B.;
Fridmans, A.;
Farkas, A.;
Belanger, A.;
Hartman, H.;
Labrie, F.

Publication type:

Article

Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 17, doi. 10.1038/pcan.2008.19

By:

Costello, L. C.;
Franklin, R. B.

Publication type:

Article

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 94, doi. 10.1038/pcan.2008.10

By:

Tucci, M.;
Mosca, A.;
Lamanna, G.;
Porpiglia, F.;
Terzolo, M.;
Vana, F.;
Cracco, C.;
Russo, L.;
Gorzegno, G.;
Tampellini, M.;
Torta, M.;
Reimondo, G.;
Poggio, M.;
Scarpa, R. M.;
Angeli, A.;
Dogliotti, L.;
Berruti, A.

Publication type:

Article

Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 25, doi. 10.1038/pcan.2008.23

By:

St John Floyd Jr., M.;
Teahan, S. J.;
Fitzpatrick, J. M.;
Watson, R. W. G.

Publication type:

Article

Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 52, doi. 10.1038/pcan.2008.26

By:

Lee, U. J.;
Jones, J. S.

Publication type:

Article

Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 61, doi. 10.1038/pcan.2008.17

By:

Nobes, J. P.;
Wells, I. G.;
Khaksar, S. J.;
Money-Kyrle, J. F.;
Laing, R. W.;
Langley, S. E. M.

Publication type:

Article

Quality of life in patients with prostate cancer: development and application of a hybrid assessment method.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 72, doi. 10.1038/pcan.2008.28

By:

Stone, P. C.;
Murphy, R. F.;
Matar, H. E.;
Almerie, M. Q.

Publication type:

Article

Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 67, doi. 10.1038/pcan.2008.20

By:

Namiki, S.;
Kwan, L.;
Kagawa-Singer, M.;
Terai, A.;
Satoh, T.;
Baba, S.;
Arai, Y.;
Litwin, M. S.

Publication type:

Article

Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 41, doi. 10.1038/pcan.2008.33

By:

Welén, K.;
Jennbacken, K.;
Tes̆an, T.;
Damber, J.-E.

Publication type:

Article

Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 78, doi. 10.1038/pcan.2008.35

By:

Imamoto, T.;
Suzuki, H.;
Yano, M.;
Kawamura, K.;
Kamiya, N.;
Araki, K.;
Komiya, A.;
Naya, Y.;
ShiraishI, T.;
Ichikawa, T.

Publication type:

Article

Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 47, doi. 10.1038/pcan.2008.37

By:

Connolly, D.;
Black, A.;
Murray, L. J.;
Nambirajan, T.;
Keane, P. F.;
Gavin, A.

Publication type:

Article

HIV and prostate cancer: a systematic review of the literature.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 6, doi. 10.1038/pcan.2008.44

By:

Silberstein, J.;
Downs, T.;
Lakin, C.;
Kane, C. J.

Publication type:

Article

Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 83, doi. 10.1038/pcan.2008.52

By:

Tunn, U. W.;
Wiedey, K.

Publication type:

Article

Prostate News.

Published in:: Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 2, doi. 10.1038/pcan.2008.59
Publication type:: Article

The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 88, doi. 10.1038/pcan.2008.36

By:

Armstrong, A. J.;
Halabi, S.;
De Wit, R.;
Tannock, I. F.;
Eisenberger, M.

Publication type:

Article

Report from Durham.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 1, doi. 10.1038/pcan.2009.1

By:

Moul, J.

Publication type:

Article